Poclight Showcases Innovative POC CLIA at MEDICA 2025

Poclight AT MEDICA 2025

MEDICA 2025, the world's largest medical equipment and technology exhibition, concluded successfully on November 20, 2025, in Düsseldorf, Germany. Held from November 17 to 20, the event covered diverse sectors including medical imaging, laboratory technology, diagnostic equipment, health information technology, physical therapy, and medical consumables, attracting over 5,000 exhibitors from more than 150 countries and regions worldwide.

Amid this grand industry gathering, Poclight made a remarkable presence with its core technologies and innovative products. Over the four-day exhibition, the core exhibits include the C5000 CLIA Chemiluminescent Immunoassay Analyzer and supporting reagents, covering both human and veterinary product lines, alongside the platelet activation testing solution.

Boasting compact portability, rapid response and high accuracy, the analyzer delivers efficient diagnostic solutions for clinical and veterinary applications.We welcomed hundreds of clients - encompassing existing partners, prospective distributors, and interested and user, with in-depth exchanges conducted with agents from Europe, the Middle East, Africa, and beyond. Discussions centered on regional medical needs and industry development trends, fostering valuable synergies for future collaboration. This further reinforced Poclight's business philosophy of "Global Layout, In-depth Value Cultivation."

Technological Breakthrough Leads New Direction for Global Expansion

The exhibition witnessed overwhelming attention on Poclight's proprietary technology –chemiluminescence Resonance Energy Transfer (CRET). This cutting-edge platform enables full-scale, integrated, and precise detection ranging from small molecules to cellular levels. With the advantage of "one-step sample addition, results available in 3–15 minutes, and minimalist operation that is simple in use yet sophisticated in design", it perfectly embodies the concept of "simplicity without compromise", realizing the lightweight global expansion of cross-border supply chains.

Demand-driven, Advancing Diagnostic Accessibility

Upholding its mission of "Innovative Diagnostics for Health" ,Poclight is committed to developing cold chain-free and easy-to-operate testing solutions. Its more stable and deployable products adapt to diverse medical scenarios, continuously enhancing the accessibility of high-quality diagnostic services worldwide.

Collaborate for Comprehensive Solutions

Looking ahead, the company will further deepen cooperation with global industry partners, covering the entire process from early warning, precise diagnosis to treatment monitoring and prognosis management. Leveraging its continuous technological innovation capabilities, Poclight aims to synergize industry forces and jointly elevate the quality of global medical services.

Poclight extends sincere gratitude to partners from all sectors for their attention and support. We look forward to meeting again at the next event to explore new industry opportunities together!